Eva Kim, MD, of ICON Eyecare, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about the ability to now use implantable collamer lenses (IOLs) in patients aged up to 60 years and why that is important.
Eva Kim, MD:
Hi, my name is Eva Kim and I am a cataract and refractive surgeon and a uveitis specialist in Denver, Colorado with ICON Eyecare. I’m also particularly interested in ICL surgery. It’s definitely my labor of love. I am excited to announce that the FDA has recently approved that ICL surgery in the United States is available to patients who are age 21 all the way up to 60. It used to be only available up to age 45, but that extra 15 years, it’s really going to make a difference.
The reason why I’m excited about it is that a lot of our patients are axial high myopes, and those patients have a higher risk of retinal detachment with intraocular surgery; intraocular surgery such as lens replacement, cataract surgery, but really not a higher risk of retinal detachment with ICL surgery. I feel that having the option of implanting ICLs in a higher myope allows a extra layer of safety for some of these patients and future-proofs the eye so that they might have other choices of lenses for cataract surgery later on in their years.
Related Content
